Dynamic Healthcare expands into e-healthImplementing its strategy to move its traditional clinical applications into e-health (PNN 10/99), Dynamic Healthcare Technologies has announced Web-based versions of three major products: e-Premier Series
Dynamic Healthcare expands into e-health
Implementing its strategy to move its traditional clinical applications into e-health (PNN 10/99), Dynamic Healthcare Technologies has announced Web-based versions of three major products: e-Premier Series laboratory information system (LIS), RadPlus radiology information system (RIS), and WebSight for Pathology. Lake Mary, FL-based Dynamic will make e-Premier LIS available as an in-house offering and as an application service provider. In the radiology market, the University of North Carolina hospitals in Chapel Hill are accessing Dynamics RadPlus RIS over the Internet. In addition, Dynamics CoPathPlus now includes WebSight for Pathology, an information system that allows pathology reports to be sent via secure socket layer encryption over the Internet.
© 2000 Miller Freeman, Inc., a United News & Media company.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.